Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.31 |
| ▸ | HTR7 | P34969 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26505113 | 0.95 | PIK3CD (0.32) | PIK3CDPIK3CBPRKDCKDM4EALDH1A1 | |
| SCHEMBL1755449 | 0.89 | ENPP3 (0.34) | PRKDCKDM4EALDH1A1HSD17B10 | |
| SCHEMBL10071383 | 0.87 | CHRNA1 (0.31) | — | |
| SCHEMBL10083826 | 0.87 | ENPP3 (0.32) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL1755450 | 0.85 | PRKDC (0.39) | PRKDC | |
| SCHEMBL4185951 | 0.85 | PRKDC (0.31) | PIK3CDPIK3CBPRKDCKDM4EALDH1A1 | |
| SCHEMBL10083047 | 0.83 | PRKDC (0.38) | PRKDC | |
| SCHEMBL10082689 | 0.83 | ARSA (0.33) | ALDH1A1HPGDHSD17B10 | |
| SCHEMBL10082687 | 0.82 | ALOX5 (0.31) | PRKDC | |
| SCHEMBL23892898 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-2441750-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-04-18 | — | — | EP | disclosed |
| EP-2423179-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-02-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | PIK3CD 4197/4885PIK3CB 4402/4885PRKDC 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.